Sanofi Aventis starts local production of new medicine for German market

Newsroom 02/11/2009 | 15:14

The company said it might start making new products in Romania, using its 30 percent production capacity from the former Sicomed factory. Sanofi Aventis has also said it is planning to start exporting the Gerovital brand. The company has finished integrating Zentiva and has structured the business into four divisions, original RX, generic RX, OTC and vaccines. It has reported a 10 percent market share by value and 16 percent by sales volume, based on information from Cegedim. “The group had totals sales of RON 730 million between August 2008 and August 2009,” said company officials. Although the businesses have been integrated, Sanofi Aventis and Zentiva will continue to operate as distinct firms, as well as corporate brands within the Sanofi Aventis group, said Dan Ivan, country manager of Sanofi Aventis Romania and president of the administration board at Zentiva.
Corina Saceanu

BR Magazine | Latest Issue

Download PDF or read online: July 2023 Issue | Business Review Magazine

The July 2023 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “At a Crossroads: Budget Deficit Endangering Romania’s Economic
Newsroom | 31/07/2023 | 14:14

    You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

    I agree with the Privacy policy of

    I agree with the storage and handling of my data by

    Advertisement Advertisement
    Close ×

    We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

    Accept & continue